Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test-Reference-Cited by-同舟云学术

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test

Published:2021-02-18 Issue:3 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Mostafa Heba H.¹^ORCID,Carroll Karen C.¹,Hicken Rachel¹,Berry Gregory J.²^ORCID,Manji Ryhana²,Smith Elizabeth²,Rakeman Jennifer L.³^ORCID,Fowler Randal C.³,Leelawong Mindy³^ORCID,Butler-Wu Susan M.⁴^ORCID,Quintero David⁴,Umali-Wilcox Minette⁴,Kwiatkowski Robert W.⁵,Persing David H.⁵,Weir Fred⁵,Loeffelholz Michael J.⁵^ORCID

Affiliation:

1. The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

2. Northwell Health Laboratories, Zucker SOM at Hofstra/Northwell, East Garden City, New York, USA

3. NYC Public Health Laboratory, Department of Health and Mental Hygiene, New York, New York, USA

4. Keck School of Medicine of USC, Department of Pathology, Los Angeles, California, USA

5. Cepheid, Sunnyvale, California, USA

Abstract

With the approach of respiratory virus season in the Northern Hemisphere, clinical microbiology and public health laboratories will need rapid diagnostic assays to distinguish severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from influenza virus and respiratory syncytial virus (RSV) infections for diagnosis and surveillance. In this study, the clinical performance of the Xpert Xpress SARS-CoV-2/Flu/RSV test (Cepheid, Sunnyvale, CA, USA) for nasopharyngeal swab specimens was evaluated in four centers: Johns Hopkins Medical Microbiology Laboratory, Northwell Health Laboratories, NYC Public Health Laboratory, and Los Angeles County/University of Southern California (LAC+USC) Medical Center.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02955-20

Reference42 articles.

1. Influenza in the COVID-19 Era

2. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

3. SARS-CoV-2 and influenza virus co-infection

4. Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan

5. Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: Results of a prospective trial (ED-POC);Journal of Infection;2024-11

2. Genomic evolution of influenza during the 2023–2024 season, the johns hopkins health system;Journal of Clinical Virology;2024-10

3. Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season;Microbiology Spectrum;2024-08-20

4. Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era;Respiratory Research;2024-06-05

5. Implementation of a Self-Audit Tool Improves Regulatory Compliance for Point-of-Care Respiratory Virus Testing in the Emergency Department;The Journal of Applied Laboratory Medicine;2024-04-04